Avalo Therapeutics, Inc. (AVTX) is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in the areas of Immunology, Immuno-oncology, and Rare Genetic Diseases.
Avalo Reports Second Quarter 2022 Financial Results and Provides Business Updates